Texas Top Legal Officer Files Lawsuit Against Tylenol Makers Regarding Autism Assertions

The top legal official in Texas Ken Paxton is suing the makers of acetaminophen, claiming the companies withheld potential risks that the pain reliever presented to pediatric brain development.

This legal action comes thirty days after Former President Trump promoted an unsubstantiated connection between consuming Tylenol - alternatively called paracetamol - during pregnancy and autism in children.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic approved for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by gaining financially from suffering and marketing drugs regardless of the risks."

The company states there is lacking scientific proof linking Tylenol to autism.

"These companies deceived for years, deliberately risking numerous people to increase profits," Paxton, from the Republican party, declared.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the well-being of US mothers and children."

On its website, Kenvue also said it had "regularly reviewed the applicable studies and there is insufficient valid information that demonstrates a established connection between taking acetaminophen and autism spectrum disorder."

Organizations acting on behalf of medical professionals and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has declared paracetamol - the main ingredient in Tylenol - is one of the few options for expectant mothers to treat pain and elevated temperature, which can present significant medical dangers if left untreated.

"In multiple decades of studies on the consumption of paracetamol in pregnancy, no reliable research has conclusively proven that the use of paracetamol in any period of pregnancy results in neurological conditions in children," the organization stated.

The court filing mentions latest statements from the Trump administration in asserting the drug is potentially dangerous.

Last month, the former president raised alarms from health experts when he told women during pregnancy to "fight like hell" not to take acetaminophen when sick.

The FDA then issued a notice that doctors should think about restricting the use of acetaminophen, while also stating that "a causal relationship" between the medication and autism spectrum disorder in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in April to conduct "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a short period.

But specialists advised that discovering a unique factor of autism - considered by experts to be the outcome of a complicated interplay of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of enduring cognitive variation and condition that impacts how people encounter and interact with the surroundings, and is identified using physician assessments.

In his lawsuit, Paxton - who supports Trump who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case seeks to make the companies "destroy any marketing or advertising" that claims acetaminophen is secure for expectant mothers.

The court case parallels the complaints of a group of parents of minors with autism spectrum disorder and ADHD who took legal action against the manufacturers of acetaminophen in two years ago.

A federal judge threw out the case, declaring investigations from the family's specialists was lacking definitive proof.